N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine can increase the activity ofβ-glucocerebrosidaseby 20%. N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine can be used in the study of lysosomal storage diseases andotherprotein storage diseases[1].
References:
[1].Francis Xavier Wilson, et al. Treatment of lysosomal storage disorders and other proteostatic diseases. WO2010015816A2. Summit Corporation Plc. 2009-08-04.
















